Video content above is prompted by the following:
- McMichael: How do you see treatment algorithms changing with the introduction of JAK inhibitor therapies?
- How do you think payers should anticipate covering AA in the next few years?
- Friedland: What do you see as the biggest unmet needs for patients with AA and how can these be improved in the future?
